Edition:
United Kingdom

Pharmaceuticals

Page 1

Abcann Enters Into Agreement To Acquire Leading Medical Cannabis Clinic

Tuesday, 12 Dec 2017

Dec 12 (Reuters) - Abcann Global Corp ::ABCANN ENTERS INTO AGREEMENT TO ACQUIRE LEADING MEDICAL CANNABIS CLINIC.AT CLOSING OF ACQUISITION, CO TO MAKE A $1.5 MILLION CASH PAYMENT AND ISSUE 1.1 MILLION COMMON SHARES IN CAPITAL OF CO.

Cannimed Commences Legal Action Against The Aurora Hostile Bid

Monday, 11 Dec 2017

Dec 11 (Reuters) - Cannimed Therapeutics Inc ::CANNIMED COMMENCES LEGAL ACTION AGAINST THE AURORA HOSTILE BID; FILES PROXY AND DIRECTORS’ CIRCULARS; URGES SHAREHOLDERS TO VOTE THEIR GREEN PROXY IN FAVOUR OF THE NEWSTRIKE ACQUISITION, AND TO TAKE NO ACTION TO REJECT AURORA’S HOSTILE BID.

Advanced Accelerator Applications Board Recommends $3.9 Bln All Cash Tender Offer By Novartis

Tuesday, 5 Dec 2017

Dec 5 (Reuters) - Advanced Accelerator Applications Sa ::ADVANCED ACCELERATOR APPLICATIONS BOARD OF DIRECTORS RECOMMENDS $3.9 BILLION ALL CASH TENDER OFFER BY NOVARTIS.ADVANCED ACCELERATOR APPLICATIONS - CO'S BOARD RECOMMENDS $3.9 BILLION ALL CASH TENDER OFFER BY NOVARTIS.

Advanced Accelerator Applications Board Recommends $3.9 Bln All Cash Tender Offer By Novartis

Tuesday, 5 Dec 2017

Dec 5 (Reuters) - Advanced Accelerator Applications Sa ::ADVANCED ACCELERATOR APPLICATIONS BOARD OF DIRECTORS RECOMMENDS $3.9 BILLION ALL CASH TENDER OFFER BY NOVARTIS.ADVANCED ACCELERATOR APPLICATIONS - CO'S BOARD RECOMMENDS $3.9 BILLION ALL CASH TENDER OFFER BY NOVARTIS.

Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of Trading Of A Shares

Monday, 4 Dec 2017

Dec 4 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::REFERS TO ANNOUNCEMENT OF COMPANY DATED 30 OCTOBER IN RELATION TO SUSPENSION OF TRADING OF A SHARES.‍AS AT 4 DEC, PROPOSED ACQUISITION IS IN PROGRESS​.GIVEN UNCERTAINTY REGARDING PROPOSED PURCHASE, CO'S A SHARES TO CONTINUE TO BE SUSPENDED.

Takashimaya to acquire Tokyo-based real estate properties for 49.5 bln yen

Friday, 1 Dec 2017

Dec 1 (Reuters) - Takashimaya Co Ltd <8233.T>:Says it signs agreement with a wholly owned unit of Takeda Pharmaceutical Co Ltd <<<4502.T>>>, to acquire two Tokyo-based real estate properties as of the end of March 2019, at the price of 49.5 billion yen in total.

Astellas acquires Mitobridge under existing collaboration

Friday, 1 Dec 2017

Nov 30 (Reuters) - Astellas Pharma Inc <4503.T>::ASTELLAS ACQUIRES MITOBRIDGE UNDER EXISTING COLLABORATION.SAYS ‍MITOBRIDGE WILL BECOME A WHOLLY-OWNED SUBSIDIARY OF ASTELLAS FOLLOWING CLOSE OF ACQUISITION​.

Augment Investments Increases Stake In Otcpharm To 99.07%

Thursday, 30 Nov 2017

Nov 30 (Reuters) - OTCPHARM ::SAID ON WEDNESDAY AUGMENT INVESTMENTS LIMITED INCREASED ITS STAKE IN COMPANY BY 12.33 PCT TO 99.07 PCT AS A RESULT OF MANDATORY TENDER OFFER.

Nippon Soda to buy plant health business from Zoetis Japan

Thursday, 30 Nov 2017

Nov 30 (Reuters) - Nippon Soda Co Ltd <4041.T>:Says it will complete acquisition of plant health business from Zoetis Japan, which is engaged in manufacture and sale of veterinary drugs, feed additives and agricultural drugs, in late March, 2018.Price not disclosed .

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary